Clearstead Advisors’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.2M | Sell |
124,028
-12,266
| -9% | -$2.22M | 0.17% | 111 |
|
|
2026
Q1 | $20.1M | Sell |
136,294
-74,375
| -35% | -$12.1M | 0.18% | 102 |
|
|
2025
Q4 | $41.1M | Sell |
210,669
-5,696
| -3% | -$1.36M | 0.52% | 44 |
|
|
2025
Q3 | $60.9M | Sell |
216,365
-5,998
| -3% | -$1.53M | 0.8% | 27 |
|
|
2025
Q2 | $48.6M | Buy |
222,363
+5,092
| +2% | +$822K | 0.68% | 32 |
|
|
2025
Q1 | $30.4M | Buy |
217,271
+1,354
| +0.6% | +$220K | 0.47% | 48 |
|
|
2024
Q4 | $36M | Sell |
215,917
-2,724
| -1% | -$484K | 0.55% | 41 |
|
|
2024
Q3 | $37.3M | Buy |
218,641
+865
| +0.4% | +$125K | 0.58% | 39 |
|
|
2024
Q2 | $30.7M | Buy |
217,776
+148,797
| +216% | +$18.5M | 0.52% | 43 |
|
|
2024
Q1 | $8.03M | Sell |
68,979
-1,412
| -2% | -$162K | 0.4% | 52 |
|
|
2023
Q4 | $7.42M | Sell |
70,391
-64,980
| -48% | -$7.09M | 0.39% | 50 |
|
|
2023
Q3 | $14.3M | Buy |
135,371
+68,358
| +102% | +$7.91M | 0.42% | 52 |
|
|
2023
Q2 | $7.98M | Buy |
67,013
+343
| +0.5% | +$35.5K | 0.48% | 44 |
|
|
2023
Q1 | $6.19M | Buy |
66,670
+8,839
| +15% | +$775K | 0.45% | 46 |
|
|
2022
Q4 | $4.73M | Buy |
57,831
+1,052
| +2% | +$79.9K | 0.37% | 59 |
|
|
2022
Q3 | $3.47M | Sell |
56,779
-240
| -0.4% | -$17.6K | 0.32% | 65 |
|
|
2022
Q2 | $3.98M | Buy |
57,019
+701
| +1% | +$51.3K | 0.31% | 68 |
|
|
2022
Q1 | $4.66M | Buy |
56,318
+859
| +2% | +$69.6K | 0.32% | 67 |
|
|
2021
Q4 | $4.84M | Buy |
55,459
+5,068
| +10% | +$476K | 0.33% | 62 |
|
|
2021
Q3 | $4.39M | Sell |
50,391
-2,017
| -4% | -$178K | 0.33% | 64 |
|
|
2021
Q2 | $4.08M | Buy |
52,408
+38
| +0.1% | +$2.98K | 0.31% | 63 |
|
|
2021
Q1 | $3.67M | Buy |
52,370
+2,119
| +4% | +$137K | 0.31% | 66 |
|
|
2020
Q4 | $3.25M | Buy |
50,251
+582
| +1% | +$34.6K | 0.3% | 65 |
|
|
2020
Q3 | $2.96M | Sell |
49,669
-237
| -0.5% | -$13.5K | 0.32% | 66 |
|
|
2020
Q2 | $2.76M | Buy |
49,906
+15,672
| +46% | +$830K | 0.32% | 64 |
|
|
2020
Q1 | $1.66M | Sell |
34,234
-2,276
| -6% | -$117K | 0.24% | 79 |
|
|
2019
Q4 | $1.93M | Buy |
36,510
+970
| +3% | +$53.4K | 0.23% | 86 |
|
|
2019
Q3 | $1.96M | Buy |
35,540
+1,529
| +4% | +$84.5K | 0.26% | 79 |
|
|
2019
Q2 | $1.94M | Buy |
34,011
+1,309
| +4% | +$70.8K | 0.26% | 82 |
|
|
2019
Q1 | $1.76M | Buy |
32,702
+261
| +0.8% | +$13.3K | 0.24% | 82 |
|
|
2018
Q4 | $1.47M | Sell |
32,441
-199
| -0.6% | -$9.54K | 0.23% | 83 |
|
|
2018
Q3 | $1.68M | Sell |
32,640
-240
| -0.7% | -$11.7K | 0.23% | 77 |
|
|
2018
Q2 | $1.45M | Sell |
32,880
-216
| -0.7% | -$9.95K | 0.21% | 81 |
|
|
2018
Q1 | $1.51M | Buy |
33,096
+7,452
| +29% | +$370K | 0.22% | 80 |
|
|
2017
Q4 | $1.21M | Buy |
25,644
+1,354
| +6% | +$66.4K | 0.16% | 91 |
|
|
2017
Q3 | $1.17M | Buy |
24,290
+1,815
| +8% | +$90.3K | 0.15% | 110 |
|
|
2017
Q2 | $1.13M | Sell |
22,475
-1,852
| -8% | -$84.4K | 0.16% | 99 |
|
|
2017
Q1 | $1.09M | Buy |
24,327
+3,719
| +18% | +$155K | 0.16% | 96 |
|
|
2016
Q4 | $792K | Buy |
+20,608
| New | +$806K | 0.13% | 105 |
|
Other funds holding ORCL
Clearstead Advisors's ORCL Position: Q2 2026 in Review
Clearstead Advisors reduced its Oracle (ORCL) stake by 9% in Q2 2026, selling an estimated $2.22M and leaving 124,028 shares worth $18.2M. The position accounts for 0.17% of the portfolio, ranked #111.
Clearstead Advisors first reported a position in ORCL in Q4 2016 and has held it in 39 quarters since. The position peaked at $60.9M in Q3 2025. 3,503 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.
- Clearstead Advisors held 124,028 shares of Oracle worth $18.2M as of Q2 2026.
- Clearstead Advisors sold 12,266 Oracle shares in Q2 2026, an estimated $2.22M.
- Oracle made up 0.17% of Clearstead Advisors's portfolio in Q2 2026, its #111 holding.
- Clearstead Advisors first reported a position in Oracle in Q4 2016 and has held it in 39 quarters since.
- Clearstead Advisors's Oracle position peaked at $60.9M in Q3 2025.
- 3,503 funds tracked by Wall St. Rank held Oracle as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.